Mode
Text Size
Log in / Sign up
N/A Completed N=25 Treatment

Reducing Disparities in the Treatment of Hypertension Using the OWL mHealth Tool

Source: ClinicalTrials.gov NCT03974334 ↗
Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: Blood Pressure Knowledge Questionnaire — 6.13 score on a scale

Summary

This is a one-year study. The study's primary outcome is successful improvement of the Our Whole Lives for Hypertension (OWL-H) online patient education platform, based upon participant use and focus group feedback, to deliver information on self-management of hypertension and other cardiac risk factors, and to encourage self-monitoring of blood pressure. Specific Aim 1 - To pilot test the OWL-H platform for 8 weeks with 26 patients with hypertension (2 groups of 13) to refine its utility for home self-monitoring (number of times patients record home blood pressure and input this data onto OWL-H and engagement of self-management (i.e. # of logins, # of mind body sessions completed, # of times modules accessed each day)). Hypothesis 1: Eighty percent of patients will log in and record their blood pressures. Specific Aim 2 - At the end of each group, hold a focus group to obtain information about: 1) the barriers and facilitators of using the OWL-H platform and using OWL-H to self-monitor blood pressure at home, 2) satisfaction with OWL-H, 3) how OWL-H helped with reduction of number of cardiac risk factors (e.g., smoking, eating habits, perceived stress, and amount of exercise and health-related quality of life).

Outcome Measures

OutcomeResultp-value
PRIMARY
Blood Pressure Knowledge Questionnaire
6.13
PRIMARY
Hypertension Self-Care Profile Self-Efficacy Instrument
65.54
PRIMARY
Mediterranean Diet Questionnaire
9
SECONDARY
Numbers of Time Blood Pressure Self-Monitoring Occurred During One Week
4.78
SECONDARY
Number of Time Blood Pressure Self-Monitoring on the OWL Platform Occurred Per Week
2.74

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects of all races and ethnicities who are English-speaking adults over the age of 18 and who have a current diagnosis of hypertension.. OWL in currently only available in English.
  • Subjects' physical and mental health status will be sufficient to be able to comprehend instructions and participate in the interventions.
  • Subjects must be able to access computer technology (cellular phone, desktop, laptop) and the internet to utilize the online OWL-H.

Exclusion Criteria

  • Serious underlying systemic or co-morbid disease, including psychotic or manic symptoms, which preclude physical or cognitive ability to participate in the intervention.

The risk-benefit ratio of the interventions for these individuals may be potentially higher than acceptable.

  • Active substance abuse, given that individuals who have active substance abuse pose a higher risk both to themselves and other members of the groups.
  • Beginning new hypertension treatments in the past week or planning to begin new hypertension treatments in the next few weeks, or planning a major medical event in the next few weeks, which would interfere with accurately determining the effect of the intervention on impact in this study.
  • Subjects who are pregnant will be not included in this study given that the risk-benefit ratio of this intervention may be higher than acceptable for these individuals due to the potential onset of non-study related gestational diabetes and/or gestational hypertension. Determination of pregnancy status will be based upon subject self-report.
  • Subjects who are not willing to participate in the intervention or attend the group visits.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03974334). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search